| |
SINGAPORE : Mainboard-listed traditional Chinese medicine group Eu Yan Sang saw net profit plunge 67 per cent to S$4.9 million for its financial year ending June 30.
This was due to restructuring charges associated with some underperforming non-core units, impairment of investment in unquoted shares as well as higher operating expenses.
Revenue improved 15 per cent to S$208.5 million.
The company said it remains cash generative, recording net operating cashflow of S$7.3 million compared to S$10.7 million a year ago.
The group also expects business conditions to continue to be challenging due to weaker consumer sentiment, currency fluctuations, and rising retail rentals and manpower costs.
The directors of the company have recommended a first and final dividend of 1 cent and a special dividend of 1 cent, making a total dividend of 2 cents per share. - CNA /ls
|
